Periampullary adenocarcinoma: Analysis of 5-year survivors

Annals of Surgery

Volumn 227, Issue 6, 1998, Pages 821-831

  Yeo, Charles J ^a,b   Sohn, Taylor A ^a   Cameron, John L ^a   Hruban, Ralph H ^a   Lillemoe, Keith D ^a   Pitt, Henry A ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PANCREAS ADENOCARCINOMA; PANCREAS SURGERY; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ACTUARIAL ANALYSIS; ADENOCARCINOMA; AGED; AMPULLA OF VATER; BILIARY TRACT SURGICAL PROCEDURES; COMMON BILE DUCT NEOPLASMS; DUODENAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PANCREATECTOMY; PANCREATIC NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0032452640     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199806000-00005     Document Type: Article

References (55)

1. Halsted WS. Contributions to the surgery of the bile passages, especially of the common bile duct. Boston Med Surg J 1899; 141:645-654.
2. Sauve L. Des pancreatectomies et specialement de la pancreatectomie cephalique. Rev Chir (Chir) 1908; 37:335-385.
3. Kausch W. Das carcinom der papilla duodeni und seine radikale Entfeinung. Beitr Z Clin Chir 1912; 78:439-486.
4. Hirschel G. Die resektion des duodenums mit der papille wegen karzinoims. Munchen Med Wochenschr 1914; 61:1728-1730.
5. Hunt VC, Budd JW. Transduodenal resection of the ampulla of Vater for carcinoma of the distal end of the common duct with restoration of continuity of the common and pancreatic ducts with the duodenum. Surg Gynecol Obstet 1935; 61:651-661.
6. Whipple AO, Parsons WB, Mullins CR. Treatment of carcinoma of the ampulla of Vater. Ann Surg 1935; 102:763-779.
7. Whipple AO. Observations on radical surgery for lesions of the pancreas. Surg Gynecol Obstet 1946; 82:623-631.
8. Brunschwig A. A one-stage pancreaticoduodenectomy. Surg Gynecol Obstet 1937; 65:681-684.
9. Tsao JI, Rossi RL, Lowell JA. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation? Arch Surg 1994; 129:405-412.
10. Andersen HB, Baden H, Brahe NEB, Burcharth F. Pancreaticoduodenectomy for periampullary adenocarcinoma. J Am Coll Surg 1994; 179:545-552.
11. Michelassi F, Erroi F, Dawson PJ, et al. Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct. Ann Surg 1989; 210:544-556.
12. Tarazi RY, Hermann RE, Vogt DP, et al. Results of surgical treatment of periampullary tumors: A 35-year experience. Surgery 1986; 100: 716-722.
13. Martin FM, Rossi RL, Dorrucci V, et al. Clinical and pathologic correlations in patients with periampullary tumors. Arch Surg 1990; 125:723-726.
14. Chan C, Herrera MF, de la Garza L, et al. Clinical behavior and prognostic factors of periampullary adenocarcinoma. Ann Surg 1995; 222:632-637.
15. Lygidakis NJ, van der Heyde MN, Allema JH, et al. Subtotal duodenopancreatectomy for pancreatic duct, distal bile duct and periampullary carcinoma: Short-and long-term results. Am J Gastroenterol 1989; 84:917-920.
16. Crile G Jr. The advantages of bypass operations over radical pancreaticoduodenectomy in the treatment of pancreatic carcinoma. Surg Gynecol Obstet 1970; 130:1049-1053.
17. Shapiro TM. Adenocarcinoma of the pancreas: a statistical analysis of biliary bypass vs. Whipple resection in good risk patients. Ann Surg 1975; 182:715-721.
18. Gudjonsson B. Carcinoma of the pancreas: critical analysis of costs, results of resections, and the need for standardized reporting. J Am Coll Surg 1995; 181:483-503.
19. Gudjonsson B. Letter to the editor. J Am Coll Surg 1996; 183:290-291 and 294.
20. Fernandez-del Castillo C, Rattner DW, Warshaw AL. Standards for pancreatic resection in the 1990s. Arch Surg 1995; 130:295-300.
21. Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, outcomes. Ann Surg 1997; 226:248-260.
22. Trede M, Schwall G, Saeger HD. Survival after pancreaticoduodenectomy: 118 consecutive resections with an operative mortality. Ann Surg 1990; 211:447-458.
23. Crist DW, Sitzmann JV, Cameron JL. Improved hospital morbidity, mortality and survival after the Whipple procedure. Ann Surg 1987; 206:358-365.
24. Gordon TA, Cameron JL. Editorial: management of patients with carcinoma of the pancreas. J Am Coll Surg 1995; 181:558-559.
25. Hruban RH, Westra WH, Phelps TH, Isacson C. Surgical pathology dissection. An illustrated guide. New York: Springer-Verlag; 1996: 72-76.
26. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 1995; 221:721-733.
27. Yeo CJ, Cameron JL. Alternative techniques for performing the Whipple operation. Adv Surg 1996; 30:293-310.
28. Cameron JL, Pitt HA, Yeo CJ, et al. One hundred and forty-5 consecutive pancreaticoduodenectomies without mortality. Ann Surg 1993; 217:430-438.
29. Yeo CJ, Hruban RH, Kern SE, et al. Adenocarcinoma of the pancreas: factors influencing outcome following pancreaticoduodenectomy -The Johns Hopkins experience. Cancer Bull 1994; 46:504-510.
30. Lillemoe KD, Cameron JL, Yeo CJ, et al. Pancreaticoduodenectomy: does it have a role in the palliation of pancreatic cancer? Ann Surg 1996; 223:718-728.
31. Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma: a spectrum of intrahepatic, perihilar and distal tumors. Ann Surg 1996; 224:463-475.
32. Talamini MA, Moesinger RC, Pitt HA, et al. Adenocarcinoma of the ampulla of Vater: a 28-year experience. Ann Surg 1997; 225:590-600.
33. Yeo CJ, Abrams RA, Grochow LB, et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single institution experience. Ann Surg 1997; 225:621-636.
34. Brat DJ, Hahn SA, Griffin CA, et al. The structural basis of molecular genetic deletions: an integration of classical cytogenetic and molecular analysis of pancreatic adenocarcinoma. Am J Pathol 1997; 150:383-391.
35. Rozenblum E, Schutte M, Goggins M, et al. Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res 1997; 57:1731-1734.
36. Moosa AR, Gamagami RA. Diagnosis and staging of pancreatic neoplasms. Surg Clin North Am 1995; 75:871-890.
37. Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993; 165:68-73.
38. Conlon KC, Klimstra DS, Brennan MF. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg 1996; 223:273-279.
39. Fortner JG, Klimstra DS, Senie RT, Maclean BJ. Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy. Ann Surg 1996; 223:147-153.
40. Spitz FR, Abbruzzese JL, Lee JE, et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 1997; 15:928-937.
41. Kayahara M, Nagakawa T, Ohta T, et al. Surgical strategy for carcinoma of the papilla of Vater on the basis of lymphatic spread and mode of recurrence. Surgery 1997; 121:611-617.
42. Willett CG, Warshaw AL, Convery K, Compton CC. Patterns of failure after pancreaticoduodenectomy for ampullary carcinoma. Surg Gynecol Obstet 1993; 176:33-38.
43. Monson JRT, Donohue JH, McEntee GP, et al. Radical resection for carcinoma of the ampulla of Vater. Arch Surg 1991; 126:353-357.
44. Delcore R Jr, Connor CS, Thomas JH, et al. Significance of tumor spread in adenocarcinoma of the ampulla of Vater. Am J Surg 1989; 158:593-597.
45. Matory YL, Gaynor J, Brennan M. Carcinoma of the ampulla of Vater. Surg Gynecol Obstet 1993; 177:366-370.
46. Pitt HA, Dooley WC, Yeo CJ, Cameron JL. Malignancies of the biliary tree. Curr Prob Surg 1995; 32:1-100.
47. Kurosaki I, Tsukada K, Hatakeyama K, Muto T. The mode of lymphatic spread in carcinoma of the bile duct. Am J Surg 1996; 172: 239-243.
48. Nagorney DM, Donohue JH, Farrell MB, et al. Outcomes after curative resections of cholangiocarcinoma. Arch Surg 1993; 128:871-877.
49. Washburn WK, Lewis WD, Jenkins RL. Aggressive surgical resection for cholangiocarcinoma. Arch Surg 1995; 130:270-276.
50. Sohn TA, Lillemoe KD, Cameron JL, et al. Adenocarcinoma of the duodenum: factors influencing long-term survival. J Gastrointest Surg 1998; 2:79-87.
51. Pickleman J, Koelsch M, Chejfec G. Node-positive duodenal carcinoma is curable. Arch Surg 1997; 132:241-244.
52. Barnes G, Romero L, Hess KR, Curley SA. Primary carcinoma of the duodenum: management and survival in 67 patients. Ann Surg Oncol 1994; 1:73-78.
53. Wade TP, Coplin MA, Virgo KS, Johnson FE. Periampullary cancer treatment in U.S. Department of Veterans Affairs hospitals: 1987-1991. Surgery 1994; 116:819-826.
54. Wade TP, El-Ghazzawy AG, Virgo KS, Johnson FE. The Whipple resection for cancer in U.S. Department of Veterans Affairs hospitals. Ann Surg 1995; 221:241-248.
55. Wade TP, Halaby IA, Stapleton DR et al. Population-based analysis of treatment of pancreatic cancer and Whipple resection: Department of Defense hospitals, 1989-1994. Surgery 1996; 120:680-687.